跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
擎乐® - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ripretinib Tablets
Approved
化学药品
Ripretinib Tablets
Deciphera Pharmaceuticals, LLC
🇨🇳 National Medical Products Administration
Approval Date
Nov 21, 2025
Approval ID
887VfyPOSW0
Company
Deciphera Pharmaceuticals, LLC
Type
化学药品
Approval Details
Approval Id
887VfyPOSW0
Approval Number
国药准字HJ20210022
Generic Name
瑞派替尼片
Generic Name En
Ripretinib Tablets
Trade Name
擎乐®
Drug Type
化学药品
Dosage Form
片剂
Strength
50mg (C₂₄H₂₁BrFN₅O₂)
Reg Date
2025-11-21
Expired Date
2030-11-20
Company Name
Deciphera Pharmaceuticals, LLC
Production Company Name
LONZA BEND INC.
Company Detail Path
/organization/deciphera-pharmaceuticals-llc
Production Company Detail Path
/organization/lonza-bend-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 21, 2025
Approval ID
887VfyPOSW0
Type
化学药品
Back to NMPA Approvals